Document is current

Article History

Received: 3 January 2022

Accepted: 7 March 2022

First Online: 21 March 2022

Change Date: 26 July 2022

Change Type: Update

Change Details: “List of collaborators name moved to acknowledgements”.

Declarations

:

: IR serves on the advisory board for Sanofi Aventis and Movi and has spoken for Aboca, Abbott, Sanofi Aventis and Eli Lilly. VC serves on the advisory board for Insulet and Eli Lilly, and his institution has received research support from AstraZeneca, Eli Lilly, and Dompè. DL has spoken for Abbott and has received support for attending meeting from Eli Lilly. AR has spoken for Menarini and Eli Lilly and has received support for attending meeting from Abbott. MM serves on the advisory board for Medtronic and Movi, has received support for attending meeting from Movi and has spoken for Abbott and Roche. EP serves on the advisory board for Medtronic and has received support for attending meeting from Movi. BP serves on the advisory board for Eli Lilly, has received support for attending meeting from Movi, Eli Lilly, Roche, and Ferring and has spoken for Sandoz. CR serves on the advisory board for Eli Lilly and has received support for attending meeting from Novo Nordisk. RS has spoken for Abbott and Lilly, has received support for attending meeting from Medtronic and Movi, and has served on advisory boards for Abbott and Sanofi. ST has spoken for Eli Lilly, Abbott, and Sanofi Aventis and serves on the advisory board for Movi. AES has spoken for Sanofi and Abbott, has received support for attending meeting from Movi and has served on the advisory board for Medtronic and Movi. CM has served on the advisory board for Novo Nordisk, Sanofi Aventis, and Abbott and has spoken for Aboca, Eli Lilly, Theras, Novo Nordisk, Sanofi Aventis, and AMryt. RB has served on the advisory board for NovoNordisk, Eli Lilly, Sanofi Aventis, Abbott, Medtronic, Movi, Roche, and Ypsomed and has received support for attending a meeting from Movi and has spoken for Eli Lilly, Abbott, and Sanofi Aventis. The other authors declare no competing interests.

: The study was approved by the coordinating center Ethical Committee (ASST Cremona) and conducted according to the Declaration of Helsinki.

: Informed consent was signed by each participants’ parents.